Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
18 Cards in this Set
- Front
- Back
Describe the processes involved in the control of emesis. |
A complex process controlled centrally in the chemoreceptor trigger zone and effected by responses in the gut, pharynx and thoracoabdominal wall (CTZ = chemorecptor trigger zone found in 'area postrema' just at the base of the skull outisde bbb, allowing for monitoring for toxins in blood stream). |
|
List different targets for antiemetic drugs and specift whether these affect the vestibular apparatus and local gut stimuli OR CTZ stimuli |
H1 Antagonist and anti-muscarinics work on Vestibular apparatus and local gut stimuli. |
|
Antihistamines for Emesis Tx, eg's and MOA |
Used for vestibular disorders (eg. motion sickness), use 1st gen so they cross BBB eg. pheniramine, promethazine and cyclizine.
S/E CNS effects such as sedation. Significant anti mACh effects contribute to their impact on motion sickness, less useful when emesis has commenced. |
|
Scopolamine, active ingredient, moa S/E |
Hyoscine hydrobromide (distinct from hyoscine butylbromide which was designed for peripheral action instead of CNS activity), acts on the CNS -depressed vestibular function helps to decrease reflexes from the chemoreceptor trigger zone that promote vomiting. |
|
Chemotherapy and nausea |
Different targets of emesis (CTZ vs. afferent) Different chemotherapy agents have different likelihood of emesis (cyclophosphomide >90%) so anti-emetics may be used in combo |
|
Anti-emetic combo |
5-HT3 and NK1 antags are used for "high risk" chemo regimens. |
|
Moa of 5HT3 antags and S/E |
5-HT3 receptor is a ligand gated cation channel therefore blocking it causes rapid desensitating depol. located at vagus nerve terminal and CTZ, reduces response to visceral stim. eg. cytotoxics. Also inhibit colonic motility (via ACh leading to constipation. |
|
Metabolism and Examples of 5HT-3 Antags |
Rely on CYPs for metabolism (3A4, 2D6) have quite long MOA that does not reflect short t1/2 administer once daily. |
|
Substance P/ NK1 antags eg's moa |
Tachykinin family of NTs, binds neurokinin-1 receptors, involved in neurogenic inflammation. |
|
Dopamine antags |
more than of catecholamines in CNS are dopamine. D2 inhibits adenylyl cyclase and found in CTZ and peripherally (GI motility) many have Anti H and AntiACh activity "general purpose" |
|
Prochlorperazine, class, MOA and S/E |
antiDA phenothiazines act directly on the CTZ, they don't have anti-psychotic effects, but can cause extrapyramidal effects and akathisia, also risk of tardive dyskinesia increases with cumulative doses / increase duration of use.
another S/E of dopamine antags= can increase QT interval |
|
What are some of the advantages of using domperidone in px with nausea/ vomiting |
acts on peripheral D2 receptors to augment gastric emptying, more difficult to vomit when the stomach is empty, domperidone has less BBB penetration so EPSE are rare |
|
Usefulness of diphenhydramine |
used in combo with Dopamine antags, it has little antiemetic capacity but prevents or treats EPSE |
|
Cannabinoids |
can have antiemetic effects, CB1 (in CNS) and (CB2 in periphery) are endogenous receptors that binds arachidonic acid metabolites, inhibits NT release. |
|
Nabilone |
is a synthetic analogue of botanical THC, CNS side effects in >10% |
|
Pancreatitis, define it and what occurs, how is it treated |
Loss of endocrine (insulin and glucagon) and exocrine (digestive enzymes and Bicarb) functions. If loss >90% function, then -> steatorrhoea and protein malabsorption. |
|
Cholestatic liver disease, define |
impairment of bile formation or flow. 'back-up' of bile can cause damage to liver leading to fibrosis. |
|
Ursodeoxycholic acid |
Ursodeoxycholic acid changes composition of bile (miscelles); stimulates hepatobiliary secretion; protection of hepatocytes against bile acid-induced apoptosis |